Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion type Assertion NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_head.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion description "[However, gemcitabine, paclitaxel, or cisplatin treatment enhanced the Akt activation, heterodimer formation of EGFR with HER3, and secretion of amphiregulin, indicating that the presence of gemcitabine promoted the activity of targeted molecules including amphiregulin, Akt, and HER3 for pancreatic cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_provenance.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion evidence source_evidence_literature NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_provenance.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion SIO_000772 20726858 NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_provenance.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion wasDerivedFrom befree-2016 NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_provenance.
- NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_assertion wasGeneratedBy ECO_0000203 NP834070.RAYci6JtMm0dFW5ZdQf20dYBVGuqNX_fPlcyLZIwNHazI130_provenance.